LISTSERV mailing list manager LISTSERV 16.0

Help for MS-CS-L Archives


MS-CS-L Archives

MS-CS-L Archives


MS-CS-L@LISTSERV.GMU.EDU


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

MS-CS-L Home

MS-CS-L Home

MS-CS-L  May 2012

MS-CS-L May 2012

Subject:

*Today* [GRAND Seminar] May 01, 2012 - 12:00-1:00 pm (Tuesday)

From:

Jyh-Ming Lien <[log in to unmask]>

Reply-To:

[log in to unmask]

Date:

Tue, 1 May 2012 03:02:01 -0400

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (75 lines)

[Apologies for multiple postings]


Email Huzefa ([log in to unmask]) if you are interested in meeting the 
speaker.


**************************************************
*
*
*    GRAND Seminar
*
*    http://cs.gmu.edu/~robotics/Main/GrandSeminar
*
*
**************************************************


   GRAND Seminar: Improving Drug Development by Connecting Medicinal
   Chemistry with Drug Repositioning and Modern Machine Learning Methods

Tuesday, May 01, 2012
12:00pm
ENGR 4201
*Iwona Weidlich*


         Abstract

Developing drug candidates from scratch has turned into a billion-dollar
expense that is not delivering enough profitable products to market.
Novel approaches which merge chemistry with biology and informatics
contribute to the development of selective lifesaving drugs needed by
patients. We implement machine learning classifiers for HTS Data
Analysis, Screening and drug repurposing with high probability of
selecting drug candidates eligible for Phase II of clinical study free
from ADME/Tox-related problems. We used small molecule bioactivity data
for HCV RNA Polymerase to train and test QSAR models and apply these
robust models for compound ranking and hit identification in drug
repositioning techniques. Random Forest and kNN algorithms were used
with Morgan fingerprints of 679 small molecules with curated IC50
values. After filtering various drug-like databases (DrugBank, MDL,
NIAID-NIH, ComGenex) compounds were selected and tested against HCV. We
discuss the challenges in drug repositioning faced in academia,
government and pharmaceutical industry.


         Speaker's Bio

Dr. Weidlich received her Ph.D. in Pharmaceutical Sciences from the
University of Medical Sciences, Poznan, Poland in 2005. Her Ph.D.
research focused on developing anti-cancer agents that are designed to
be activated only inside a cancerous cell but have benign form in the
systemic circulation. Her research interests also include using very
large collections of chemical databases to filter and extract relevant
subsets of molecules for closer analysis, and performing physicochemical
and ADME/Tox property predictions. Specifically, she is interested in
designing and evaluation of novel anti-cancer agents. She joined the
Computer-Aided Drug Design (CADD) group at the Chemical Biology
Laboratory, National Cancer Institute in Frederick, NIH as a
postdoctoral fellow in October 2005. Dr. Weidlich has been conducting in 
silico screening for the inhibitors of cancer DNA, specifically
tyrosyl-DNA phosphodiesterase (Tdp1) and Shc Src homology 2 (SH2)
domain. She designed new, more powerful Tdp1 inhibitors and Shc SH2
domain-binding inhibitors: tetramer peptide-peptoid hybrids exhibiting
up to 40-fold increase in affinity.

-- 
Jyh-Ming Lien
Assistant Professor, George Mason University
+1-703-993-9546

MASC Group: http://masc.cs.gmu.edu
Homepage: http://cs.gmu.edu/~jmlien

Top of Message | Previous Page | Permalink

Advanced Options


Options

Log In

Log In

Get Password

Get Password


Search Archives

Search Archives


Subscribe or Unsubscribe

Subscribe or Unsubscribe


Archives

October 2021
August 2021
February 2021
January 2021
August 2020
July 2020
April 2020
February 2020
May 2019
January 2019
September 2018
August 2018
June 2018
April 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
May 2017
April 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
July 2016
June 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
July 2014
June 2014
April 2014
March 2014
February 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
May 2012
April 2012
March 2012
February 2012
January 2012
November 2011
October 2011
September 2011
July 2011
June 2011
May 2011
April 2011
March 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009

ATOM RSS1 RSS2



LISTSERV.GMU.EDU

CataList Email List Search Powered by the LISTSERV Email List Manager